Preview Mode Links will not work in preview mode
Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape.  Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes  Value-based healthcare  Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials  Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Aug 2, 2017

Dr. Dror Harats, Founder and CEO of VBL Therapeutics, talks about the limitations of current treatments for recurrent glioblastoma multiforme (rGBM), the most common and deadliest form of brain cancer in adults and the challenges in developing new treatments to combat this devastating disease. The good news is that their lead candidate, a biologic agent called VB-111, is in late-stage clinical development for rGBM and showing great promise. He discusses the unique mechanism of VB-111 that he hopes could hold the key not only to treating rGBM, but many types of cancer.

@VBL Therapeutic

#GBM.  #Glioblastoma. 

#BrainTumor   #BrainCancer.  #Cancer

VBL Therapeutics VBLRX.com